Ubon Bio Ethanol PCL

Ubon Bio Ethanol maintains a debt-to-equity ratio of 0.44, indicating a relatively conservative capital structure compared to the industry median of 0.65. The company's liquidity position is assessed as medium, with a current ratio of 1.39 and negative net cash after subtracting total debt. Free cash flow of 170.7 million THB in the latest period suggests some capacity to fund operations or reduce debt, though operating cash flow was negative at -1.46 billion THB. Profitability metrics show a return on equity of 1.84% and a return on assets of 1.19%, both below the industry median of 3.2% and 2.8%, respectively. Gross profit of 286.5 million THB and operating income of 133.3 million THB reflect modest margins in a competitive refining and marketing environment. The company's net income of 107.6 million THB is supported by cost controls but remains constrained by input price volatility. The company's revenue is concentrated in Thailand, with no disclosed international operations. Segment data is not available, but the single-product focus on bioethanol exposes the company to regulatory and feedstock price risks. The lack of geographic diversification increases vulnerability to local economic and policy shifts. Revenue growth is expected to remain flat in the current fiscal year, with a projected decline of 2.1% in the next fiscal year. This outlook is driven by saturated domestic demand and limited export opportunities. Capital expenditure of -37.2 million THB in the latest period suggests minimal investment in expansion, aligning with the company's current strategy of operational efficiency. Risk factors include liquidity constraints and exposure to volatile feedstock prices. The company's liquidity risk is moderate, but the negative operating cash flow raises concerns about short-term solvency. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. However, the company's reliance on debt financing could increase leverage if operating performance deteriorates. Recent filings and transcripts highlight the company's focus on cost optimization and compliance with environmental regulations. No material events have been disclosed in the past quarter that would significantly alter the company's strategic direction or financial position.